{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:46:14Z","timestamp":1788572774564,"version":"build-2803163510"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00577","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T05:22:05Z","timestamp":1553577725000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17\/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses"],"prefix":"10.3389","volume":"10","author":[{"given":"Florence","family":"Ecoeur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Kaupmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Hintermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Orain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Guntermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.immuni.2008.03.001","article-title":"Th17 cell differentiation: the long and winding road","volume":"28","author":"McGeachy","year":"2008","journal-title":"Immunity."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature."},{"key":"B4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ng.513","article-title":"Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci","volume":"42","author":"Australo-Anglo-American Spondyloarthritis","year":"2010","journal-title":"Nat Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","article-title":"Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions","volume":"43","author":"Patel","year":"2015","journal-title":"Immunity."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E2684","DOI":"10.3390\/ijms18122684","article-title":"Molecular mechanisms and management of a cutaneous inflammatory disorder: psoriasis","volume":"18","author":"Woo","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-med-051914-021944","article-title":"Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases","volume":"67","author":"Fragoulis","year":"2016","journal-title":"Annu Rev Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br J Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.4049\/jimmunol.1001538","article-title":"Cutting edge: a critical functional role for IL-23 in psoriasis","volume":"185","author":"Tonel","year":"2010","journal-title":"J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Transl Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40261-017-0500-9","article-title":"Safety and efficacy of brodalumab for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis","volume":"37","author":"Attia","year":"2017","journal-title":"Clin Drug Investig."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell."},{"key":"B19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","article-title":"Th17: an effector CD4 T cell lineage with regulatory T cell ties","volume":"24","author":"Weaver","year":"2006","journal-title":"Immunity."},{"key":"B20","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.11131\/2015\/101185","article-title":"Retinoic acid-Related Orphan Receptors (RORs): regulatory functions in immunity, development, circadian rhythm, and metabolism","volume":"2","author":"Cook","year":"2015","journal-title":"Nucl Receptor Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell."},{"key":"B24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.4049\/jimmunol.0900368","article-title":"Tc17 CD8 T cells: functional plasticity and subset diversity","volume":"183","author":"Yen","year":"2009","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/eji.201242569","article-title":"IL-17-producing gammadelta T cells and innate lymphoid cells","volume":"42","author":"Sutton","year":"2012","journal-title":"Eur J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","article-title":"Innate lymphoid cells: emerging insights in development, lineage relationships, and function","volume":"30","author":"Spits","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.gastro.2008.10.018","article-title":"RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F","volume":"136","author":"Leppkes","year":"2009","journal-title":"Gastroenterology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1172\/JCI61862","article-title":"Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice","volume":"122","author":"Pantelyushin","year":"2012","journal-title":"J Clin Invest."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1016\/j.bmcl.2016.08.012","article-title":"Recent progress on nuclear receptor RORgamma modulators","volume":"26","author":"Cyr","year":"2016","journal-title":"Bioorg Med Chem Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10976","DOI":"10.1021\/acs.jmedchem.8b00588","article-title":"Combating autoimmune diseases with retinoic acid receptor-Related Orphan Receptor-gamma (RORgamma or RORc) inhibitors: hits and misses","volume":"61","author":"Pandya","year":"2018","journal-title":"J Med Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/aps.2014.120","article-title":"ROR nuclear receptors: structures, related diseases, and drug discovery","volume":"36","author":"Zhang","year":"2015","journal-title":"Acta Pharmacol Sin."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1002\/cmdc.201600500","article-title":"Synthesis and biological evaluation of new triazolo- and imidazolopyridine RORgammat inverse agonists","volume":"11","author":"Hintermann","year":"2016","journal-title":"ChemMedChem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/cmdc.201700278","article-title":"Structural states of RORgammat: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds","volume":"12","author":"Kallen","year":"2017","journal-title":"ChemMedChem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"beta-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.jid.2018.02.030","article-title":"Resident T cells in resolved psoriasis steer tissue responses that stratify clinical outcome","volume":"138","author":"Gallais Serezal","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12864-015-1508-2","article-title":"Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN","volume":"16","author":"Keermann","year":"2015","journal-title":"BMC Genomics."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/jid.2014.532","article-title":"IL-36gamma (IL-1F9) is a biomarker for psoriasis skin lesions","volume":"135","author":"D'Erme","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/exd.13722","article-title":"The human IL-17A\/F heterodimer regulates psoriasis-associated genes through IkappaBzeta","volume":"27","author":"Bertelsen","year":"2018","journal-title":"Exp Dermatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/jid.2014.383","article-title":"Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6","volume":"135","author":"Wu","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1021\/cb200496y","article-title":"Identification of SR2211: a potent synthetic RORgamma-selective modulator","volume":"7","author":"Kumar","year":"2012","journal-title":"ACS Chem Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.1021\/jm1004286","article-title":"Discovery of CP-690,550:a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection","volume":"53","author":"Flanagan","year":"2010","journal-title":"J Med Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e91127","DOI":"10.1172\/jci.insight.91127","article-title":"Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations","volume":"2","author":"Guntermann","year":"2017","journal-title":"JCI Insight."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0188391","DOI":"10.1371\/journal.pone.0188391","article-title":"Pharmacological inhibition of RORgammat suppresses the Th17 pathway and alleviates arthritis in vivo","volume":"12","author":"Guendisch","year":"2017","journal-title":"PLoS ONE."},{"key":"B46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1677\/jme.0.0230255","article-title":"Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription","volume":"23","author":"Collingwood","year":"1999","journal-title":"J Mol Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.4049\/jimmunol.0903243","article-title":"RORC2 is involved in T cell polarization through interaction with the FOXP3 promoter","volume":"184","author":"Burgler","year":"2010","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cytogfr.2010.10.006","article-title":"Signal transduction pathways and transcriptional regulation in Th17 cell differentiation","volume":"21","author":"Hirahara","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: the Yin and the Yang","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.4049\/jimmunol.179.6.4135","article-title":"IL-17 enhances chemokine gene expression through mRNA stabilization","volume":"179","author":"Hartupee","year":"2007","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2014.04.004","article-title":"Small-molecule RORgammat antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms","volume":"40","author":"Xiao","year":"2014","journal-title":"Immunity."},{"key":"B54","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ni.3748","article-title":"The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells","volume":"18","author":"Geng","year":"2017","journal-title":"Nat Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.4049\/jimmunol.175.6.3800","article-title":"RORgammat recruits steroid receptor coactivators to ensure thymocyte survival","volume":"175","author":"Xie","year":"2005","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell."},{"key":"B57","doi-asserted-by":"publisher","first-page":"16355","DOI":"10.1038\/srep16355","article-title":"Reciprocal regulation of RORgammat acetylation and function by p300 and HDAC1","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature."},{"key":"B60","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"17003","DOI":"10.1074\/jbc.M801286200","article-title":"Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat","volume":"283","author":"Ichiyama","year":"2008","journal-title":"J Biol Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1038\/jid.2014.308","article-title":"IL-19 is a component of the pathogenetic IL-23\/IL-17 cascade in psoriasis","volume":"134","author":"Witte","year":"2014","journal-title":"J Invest Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","article-title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","volume":"392","author":"Gordon","year":"2018","journal-title":"Lancet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N Engl J Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"10088","DOI":"10.1073\/pnas.1801377115","article-title":"IkappaBzeta is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes","volume":"115","author":"Muller","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4062\/biomolther.2012.20.2.171","article-title":"HaCaT keratinocytes and primary epidermal keratinocytes have different transcriptional profiles of cornified envelope-associated genes to T helper cell cytokines","volume":"20","author":"Seo","year":"2012","journal-title":"Biomol Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/jid.2014.146","article-title":"Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients","volume":"134","author":"Teunissen","year":"2014","journal-title":"J Invest Dermatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J Invest Dermatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1096\/fj.13-242040","article-title":"RORalpha and ROR gamma are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D","volume":"28","author":"Slominski","year":"2014","journal-title":"FASEB J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"11434","DOI":"10.1038\/s41598-017-10202-7","article-title":"Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols","volume":"7","author":"Slominski","year":"2017","journal-title":"Sci Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11154-011-9194-0","article-title":"Vitamin D and the skin: physiology and pathophysiology","volume":"13","author":"Bikle","year":"2012","journal-title":"Rev Endocr Metab Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jsbmb.2016.09.024","article-title":"Endogenously produced nonclassical vitamin D hydroxy-metabolites act as \u201cbiased\u201d agonists on VDR and inverse agonists on RORalpha and RORgamma","volume":"173","author":"Slominski","year":"2017","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B75","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2340\/00015555-1642","article-title":"Association of 25-hydroxyvitamin D with metabolic syndrome in patients with psoriasis: a case-control study","volume":"94","author":"Orgaz-Molina","year":"2014","journal-title":"Acta Derm Venereol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/ijd.12790","article-title":"The role of vitamin D in psoriasis: a review","volume":"54","author":"Soleymani","year":"2015","journal-title":"Int J Dermatol."},{"key":"B77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2340\/00015555676568","article-title":"Abnormal vitamin D metabolism in patients with psoriasis","volume":"67","author":"Staberg","year":"1987","journal-title":"Acta Derm Venereol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jaad.2012.10.051","article-title":"Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis","volume":"68","author":"Ricceri","year":"2013","journal-title":"J Am Acad Dermatol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00577\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:46:11Z","timestamp":1694727971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00577\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2019.00577"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00577","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"article-number":"577"}}